Lactoferrin for Respiratory Infections: Upper Respiratory Evidence
Expert Summary
Several RCTs and prospective studies show lactoferrin supplementation reduces upper respiratory tract infection (URTI) frequency and duration in adults. The mechanisms operating at the nasopharyngeal mucosa — direct antiviral HSPG-blocking, bacteriostatic iron sequestration, and NK cell activation — are particularly active at the primary infection site of respiratory viruses.
Key Facts
- URTI prevention trials: A systematic review of 8 trials in children and adults found lactoferrin supplementation significantly reduced URTI frequency (pooled RR 0.67, 95% CI 0.55–0.82). Daily supplementation of 200–300 mg/day in winter provides measurable protective benefit.
- Duration reduction: When infections do occur, lactoferrin supplementation is associated with 25–35% reduction in symptom duration vs control groups — consistent with accelerated viral clearance via enhanced innate immune response.
- Nasal administration research: Intranasal lactoferrin (as used in the Campione COVID-19 trial) delivers the protein directly to the upper respiratory mucosa. While not widely commercially available, nasal lactoferrin sprays are an active research area.
- Children's evidence: Particularly strong evidence exists for lactoferrin supplementation reducing URTIs in children attending daycare — a high-transmission setting where URTI incidence is a major pediatric health concern.
- Seasonal dosing: Some practitioners use 200 mg/day lactoferrin year-round and increase to 300–400 mg/day in winter (October–April in Northern Hemisphere) when URTI incidence peaks.
- Influenza specifically: In vitro studies show lactoferrin inhibits influenza A and B virus adsorption to cells. Human data is observational; no specific influenza RCT has been completed.
Recommended Products
Frequently Asked Questions
Should I increase lactoferrin dose when I feel a cold coming on?
Yes. Increasing lactoferrin to 400–600 mg/day at the first sign of respiratory symptoms (within the first 24–48 hours) provides the strongest antiviral benefit by flooding mucosal surfaces with the protein during active viral replication.
Is lactoferrin better than vitamin C or zinc for colds?
Lactoferrin, vitamin C, and zinc have different mechanisms and are complementary. Lactoferrin provides direct antiviral and bacteriostatic effects; vitamin C supports immune cell function; zinc provides ionophore-mediated antiviral activity. Combining all three at symptom onset provides the broadest antiviral coverage.
Scientific References
- Berlutti F et al. Antiviral properties of lactoferrin. Molecules. 2011. PMID: 21847071
- Drago-Serrano ME et al. Lactoferrin and gut microbiota. Current Pharmaceutical Design. 2019